<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE331nnn/GSE331349/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE331349</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Complex I Drives Glutamine-Dependent TCA Cycle to Support Viability of MYChigh Breast Cancer Cells</name><description>In many cancers, stably elevated MYC levels drive persistent and concerted activation of cell growth promoting anabolic programs and cell cycle in ways distinct from normal cells. Therefore, synthetic-lethal targeting of MYC-reprogrammed pathways offers selective strategies against MYChigh tumors. This study identifies enhanced mitochondrial respiration as a hallmark of MYC overexpressing cancer cells. Mitochondrial respiration sustains TCA cycle by regenerating NAD+ through complex I-mediated oxidation of NADH. Metabolic carbon tracing analysis reveals that MYC shifts TCA cycle carbon source from glucose to glutamine. Inhibition of the glutamine-fueled TCA cycle using NAD+-depleting complex I inhibitors promotes MYC-dependent synthetic lethality in breast cancer cells. In mouse models of MYChigh tumors, persistent inhibition of tumor growth is achieved through combined inhibition of complex I and glutaminolysis. Altogether, the high respiration rate observed in MYChigh cells supports a glutamine carbon-enriched TCA cycle rendering MYChigh tumors selectively vulnerable to inhibitors of mitochondrial respiration and glutaminolysis. This deposition specifically contains the RNA-sequencing data generated from the breast cancer cell lines described in the study.</description><dates><publication>2026/05/19</publication></dates><accession>GSE331349</accession><cross_references><GSM>GSM9744449</GSM><GSM>GSM9744448</GSM><GSM>GSM9744469</GSM><GSM>GSM9744447</GSM><GSM>GSM9744464</GSM><GSM>GSM9744486</GSM><GSM>GSM9744485</GSM><GSM>GSM9744463</GSM><GSM>GSM9744484</GSM><GSM>GSM9744462</GSM><GSM>GSM9744461</GSM><GSM>GSM9744483</GSM><GSM>GSM9744446</GSM><GSM>GSM9744468</GSM><GSM>GSM9744467</GSM><GSM>GSM9744445</GSM><GSM>GSM9744466</GSM><GSM>GSM9744444</GSM><GSM>GSM9744488</GSM><GSM>GSM9744487</GSM><GSM>GSM9744465</GSM><GSM>GSM9744482</GSM><GSM>GSM9744460</GSM><GSM>GSM9744481</GSM><GSM>GSM9744480</GSM><GSM>GSM9744459</GSM><GSM>GSM9744458</GSM><GSM>GSM9744475</GSM><GSM>GSM9744453</GSM><GSM>GSM9744452</GSM><GSM>GSM9744474</GSM><GSM>GSM9744473</GSM><GSM>GSM9744451</GSM><GSM>GSM9744472</GSM><GSM>GSM9744450</GSM><GSM>GSM9744479</GSM><GSM>GSM9744457</GSM><GSM>GSM9744478</GSM><GSM>GSM9744456</GSM><GSM>GSM9744455</GSM><GSM>GSM9744477</GSM><GSM>GSM9744476</GSM><GSM>GSM9744454</GSM><GSM>GSM9744471</GSM><GSM>GSM9744470</GSM><GPL>18573</GPL><GSE>331349</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>